Low ERK phosphorylation in cancer-associated fibroblasts is associated with tamoxifen resistance in pre-menopausal breast cancer.

Authors
Busch, Susann
Rydén, L
Stål, O
Jirström, K
Landberg, Göran
Affiliation
Breakthrough Breast Cancer Research Unit, School of Cancer, Enabling Sciences and Technology, University of Manchester, Manchester Academic Health Science Centre, Paterson Institute for Cancer Research, The Christie NHS Foundation Trust, Manchester, United Kingdom.
Issue Date
2012

Metadata
Show full item record
Abstract
The aim of this study was to evaluate ERK phosphorylation as a stromal biomarker for breast cancer prognosis and tamoxifen treatment prediction within a randomized tamoxifen trial.
Citation
Low ERK phosphorylation in cancer-associated fibroblasts is associated with tamoxifen resistance in pre-menopausal breast cancer. 2012, 7 (9):e45669 PLoS ONE
Journal
PloS One
URI
http://hdl.handle.net/10541/262494
DOI
10.1371/journal.pone.0045669
PubMed ID
23029174
Type
Article
Language
en
ISSN
1932-6203
Collections